Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mallinckrodt Plc (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,987,419
  • Shares Outstanding, K 83,505
  • Annual Sales, $ 3,216 M
  • Annual Income, $ -3,607,000 K
  • 60-Month Beta 2.31
  • Price/Sales 0.61
  • Price/Cash Flow 1.28
  • Price/Book 0.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.79
  • Number of Estimates 6
  • High Estimate 1.98
  • Low Estimate 1.70
  • Prior Year 1.31
  • Growth Rate Est. (year over year) +36.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.40 +16.67%
on 03/08/19
27.33 -12.92%
on 02/26/19
+3.28 (+15.98%)
since 02/21/19
3-Month
15.18 +56.79%
on 12/27/18
27.33 -12.92%
on 02/26/19
+7.77 (+48.47%)
since 12/21/18
52-Week
11.65 +104.29%
on 05/04/18
36.65 -35.06%
on 08/20/18
+9.23 (+63.35%)
since 03/21/18

Most Recent Stories

More News
Mallinckrodt (MNK) Gains But Lags Market: What You Should Know

Mallinckrodt (MNK) closed the most recent trading day at $23.80, moving +0.59% from the previous trading session.

MNK : 23.80 (+0.59%)
Mallinckrodt has the Best Relative Performance in the Pharmaceuticals Industry (MNK , MDCO , COLL , MYL , MRK )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

COLL : 17.00 (-3.41%)
MDCO : 28.02 (+3.59%)
MNK : 23.80 (+0.59%)
Mallinckrodt Rises 2.69% on Heavy Volume: Watch For Potential Pullback

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $22.88 to a high of $23.36. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $22.71...

MNK : 23.80 (+0.59%)
Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients

The FDA approves Allergan's (AGN) sNDA for the label expansion of its antibacterial medicine, Avycaz, to treat cUTI and cIAI in pediatric patients.

CELG : 89.63 (+1.43%)
AGN : 153.53 (-0.09%)
MNK : 23.80 (+0.59%)
PFE : 42.35 (+0.43%)
Top Ranked Value Stocks to Buy for March 19th

Top Ranked Value Stocks to Buy for March 19th

DAN : 18.07 (+1.75%)
WAL : 41.30 (-2.29%)
MNK : 23.80 (+0.59%)
ASM : 0.63 (+1.42%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Omeros Corp (OMER , MNK , COLL , RVNC , ENDP )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

COLL : 17.00 (-3.41%)
MNK : 23.80 (+0.59%)
OMER : 17.72 (+0.91%)
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that, following an extensive search, Bryan Reasons has been appointed Chief Financial Officer (CFO), effective...

MNK : 23.80 (+0.59%)
Mallinckrodt Up 17.2% Since SmarTrend Uptrend Call (MNK)

SmarTrend identified an Uptrend for Mallinckrodt (NYSE:MNK) on January 8th, 2019 at $18.72. In approximately 2 months, Mallinckrodt has returned 17.23% as of today's recent price of $21.94.

MNK : 23.80 (+0.59%)
Mallinckrodt's Hobart, N.Y. and St. Louis, Mo. Sites Recognized as 2019 Manufacturing Leadership Award Winners

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading specialty pharmaceutical company, announced today that sites owned and operated by subsidiaries in its Specialty Generics business have been recognized...

MNK : 23.80 (+0.59%)
Watch for Mallinckrodt to Potentially Pullback After Gaining 1.00% Yesterday

Mallinckrodt (NYSE:MNK) traded in a range yesterday that spanned from a low of $21.87 to a high of $22.14. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $22.04...

MNK : 23.80 (+0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More Share

Trade MNK with:

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 24.58
1st Resistance Point 24.19
Last Price 23.80
1st Support Level 23.34
2nd Support Level 22.89

See More

52-Week High 36.65
Fibonacci 61.8% 27.10
Fibonacci 50% 24.15
Last Price 23.80
Fibonacci 38.2% 21.20
52-Week Low 11.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar